Ultragenyx Pharmaceutical Inc. granted 22,917 restricted stock units to six newly hired non-executive officers under its Employment Inducement Plan. The awards have a Feb. 16, 2026 grant date and vest over four years, with 25% vesting on each anniversary of the grant date, subject to continued employment.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9656122-en) on February 20, 2026, and is solely responsible for the information contained therein.